Viewing Study NCT04065269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-04 @ 9:47 AM
Study NCT ID: NCT04065269
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2019-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss
Sponsor: Institute of Cancer Research, United Kingdom
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gynaecological Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Clear cell ovarian carcinoma View
None Clear cell endometrial carcinoma View
None Endometrioid carcinoma View
None Carcinosarcoma View
None Cervical carcinoma View
None ARID1A View
None Endometrial cancer View